InvestorsHub Logo
Followers 80
Posts 24702
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 04/13/2017 9:11:54 AM

Thursday, April 13, 2017 9:11:54 AM

Post# of 27621
CLSN - .2965 Pre-market now at .3645/.371

Celsion Corporation Reports Preclinical Results of ThermoDox® for the Treatment of Bladder Cancer Published in the International Journal of Hyperthermia



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.